NCOG-32. THE SAFETY AND EFFICACY OF DEXAMETHASONE IN THE MANAGEMENT OF GLIOMA PATIENTS

Dexamethasone is routinely administered to glioma patients for the management of cerebral edema. Dexamethasone is associated with significant side effects including hyperglycemia, increased risk of infection, and impaired anti-tumor immune response. Despite these risks, there are no standardized gui...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Medikonda, Ravi, Patel, Kisha, Saleh, Laura, Srivastava, Siddhartha, Jackson, Christina, Mohan, Aditya, Weingart, Jon, Bettegowda, Chetan, Gallia, Gary, Brem, Henry, Lim, Michael
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Outcome Measures and Neuro-Cognitive Outcomes
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651049/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.570
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars